Intellectual Property
KEI, ICDRI, AHEAD, NYBIDA and Lighthouse file comments on WIPO treaty for reading disabilities
Submitted by Manon Ress on 13. November 2009 - 13:34Today five groups filed the attached comments to the U.S. Copyright Office and the USPTO regarding the WIPO draft proposal to facilitate access to copyrighted works for persons, who are blind, have visual impairments and other reading disabilities in response to the Federal Register Notice of October 13, 2009.
The comments were signed by
- Dr. Manon Ress, Knowledge Ecology International (KEI)
USTR Ron Kirk's September 30, 2009 Speech on Intellectual Property
Submitted by James Love on 5. October 2009 - 14:07USTR head Ambassador Ron Kirk made another speech on intellectual property on September 30, 2009. The text of his speech is here. Below are a few relevant quotes.
On access to medicine:
The U.S. Special 301 Reports, 1989 to 2010
The USTR's Special 301 Report has been issued every year beginning in 1989. The Executive Summary of the 2009 report says:
KEI statement on adoption of Eshoo/Barton amendment
Submitted by James Love on 31. July 2009 - 12:00In a roll call vote, the Eshoo/Barton amendment passed by a vote of 47 to 11. A number of consumer groups are issuing statements. This is the KEI statement on the vote.
James Love, Director Knowledge Ecology International (KEI),
(+1) (202) 361-3040, james.love@keionline.org
ACTA and changes in global norms for damages and injunctions (for enforcement of intellectual property)
Submitted by James Love on 31. July 2009 - 12:00The Obama Administration, with the support of a Democrat-controlled U.S. Congress, is insisting the Anti-Counterfeiting Trade Agreement (ACTA) negotiations be conducted in secret. We know, from documents obtained in Europe and the summaries released in April 2009, that the draft ACTA has sections that deal with both injunctions and damages. We don’t have the current text.
Broken promise by President Obama on parallel trade in pharmaceuticals
Submitted by James Love on 23. July 2009 - 22:00As candidates, almost all democrats have promised voters, in several elections, they will support parallel trade in pharmaceuticals from Canada and other high income countries. As elected officials, nothing happens. President Obama already has authority to permit imports of medicines, if he wanted to exercise it. But not only is the White House not fullfillinbg the promise to allow imports, it has promised the CEO of PhRMA and several big companies that they won’t allow parallel trade in the health reform bill.
Margaret Chan on “new initiatives, and new incentive schemes”
Submitted by thiru on 13. July 2009 - 22:00At the WIPO Conference on Intellectual Property and Public Policy Issues today, Margaret Chan, the Director General of the World Health Organization, made the following speech at WIPO’s Conference on Intellectual Property and Public Policy Issues on the topic of “Strengthening Multilateral Cooperation on IP and Public Health” where she shared the limelight with Pascal Lamy, Director General of the World Trade Organ
Jan 12-13, 2009. Patents, Copyrights and Knowledge Governance, the next four years
Submitted by Staff on 11. January 2009 - 23:00TransAtlantic Consumer Dialogue, Washington, DC.
The TACD conference on Patents, Copyrights and Knowledge Governance: the next fours years is going to be held on January 12-13th, 2009 in Washington, DC.
Venue: Carnegie Institution of Washington • 1530 P Street NW • Washington, DC 20005
The event is free and is now open for registrations on the TACD website: http://www.tacd.org/events/patents_2009.htm
The Health Impact Fund and product monopolies
Submitted by James Love on 17. November 2008 - 11:00KEI will later issue a more detailed comment on the Health Impact Fund. One of the key issues that will be addressed is the way that Hollis and Pogge propose turning the prize fund proposals that are based upon open licensing of patents into something that reinforces the monopoly supply chain.
We understand that one motivation for doing this was to attract support from some large pharmaceutical companies, and the European governments that protect them.
November 13, 2008. KEI brownbag on US Priority Review Voucher
Submitted by Staff on 12. November 2008 - 23:00US Priority Review Voucher
Time: 12:00pm-2:30pm, Thursday, 13 November 2008Knowledge Ecology International (formerly CPTech)1621 Connecticut Avenue NW, Suite 500 (5th Floor)Washington DC, 20009Tel: +1 202 332 2670
PARTICIPANTS
Aaron Kesselheim , Brigham and Women's Hospital/Harvard School of Public Health, Harvard University
David Ridley , The Fuqua School of Business, Duke University
James Love, KEI